Instead of only treating symptoms, longevity medicine focuses on prevention, cellular health, and system-wide balance so you can stay strong, energized, and resilient as you age
Clinical trials and real-world data consistently show significant weight loss from treatment with Ozempic, Semaglutide and Tirzepatide: Unfortunately, weight regain is a well-documented phenomenon after discontinuation of treatment: SURMOUNT 4 trial- Weight regain after stopping Tirzepatide after 36 weeks versus continuation of treatment Beyond weight regain, the discontinuation of GLP-1 agonists may reverse cardiometabolic benefits: Ongoing trials (e.g., SELECT and SURPASS-CVOT) aim to clarify whether continued use is necessary for sustained cardiovascular risk reduction
If the pill is not absorbed correctly because of food interference, it wont work as well as the injection
The treatment has minimal downtime
FTC Affiliate Disclosure: This advertorial contains affiliate links
It is a comprehensive program designed to remove the financial stress often associated with GLP-1 weight loss treatments